For thirty-one years, our mission has been to provide state-of-the-art information on breast cancer research. From a one-day regional conference the symposium has grown to a four-day program attended by a broad international audience of academic and private researchers and physicians from over 80 countries.
The symposium aims to achieve a balance of clinical, translational, and basic research, providing a forum for interaction, communication, and education for a broad spectrum of researchers, health professionals, and those with a special interest in breast cancer.
In 2007, the Cancer Therapy & Research Center (CTRC) at UT Health Science Center San Antonio and the American Association for Cancer Research (AACR) announced a collaboration for the future of the San Antonio Breast Cancer Symposium. The symposium has been renamed the CTRC-AACR San Antonio Breast Cancer Symposium. Complementing the clinical strengths of the highly regarded annual San Antonio Breast Cancer Symposium, the AACR's scientific prestige in basic, translational and clinical cancer research will create a unique and comprehensive scientific meeting that will advance breast cancer research for the benefit of patients.
In 2005, Baylor College of Medicine became a joint sponsor of the symposium and will remain in the CTRC-AACR collaboration.
Charles A. Coltman, Jr., MD, Professor of Medicine, UT Health Science Center, President Emeritus, Cancer Therapy & Research Center and C. Kent Osborne, MD, Director, Dan L. Duncan Cancer Center, Baylor College of Medicine remain Co-Directors of the symposium.
The objective of the SABCS is to provide state-of-the-art information
on the experimental biology, etiology, prevention, diagnosis,
and therapy of breast cancer and premalignant disease,
to an international audience of academic and private physicians
and researchers.
The scientific program consists of invited lectures and mini-symposia
by experts in clinical and basic research, selected slide and
poster presentations chosen from the submitted abstracts, and case discussions. General sessions are
2-3 hours in duration and are the vehicle for slide presentations,
which are allotted 10 minutes each followed by 5 minutes of discussion.
Poster sessions are each 2 hours long.
This international symposium is directed primarily towards
academic and private physicians and researchers involved in breast
cancer in medical, surgical, gynecologic, and radiation oncology,
as well as other appropriate health care professionals.
All administrative functions of the San Antonio Breast Cancer
Symposium occur in the symposium operations office, which is located
at University Plaza Building, 7526 Louis Pasteur, Room 121, San Antonio, Texas 78229.
Financial Philosophy
Any remaining funds at the conclusion of the CME activity will be used for educational research purposes.
Charles A. Coltman,
Jr, UT Health Science Center, San Antonio, TX
C. Kent Osborne, Dan L. Duncan Cancer Center,
Baylor College of Medicine,
Houston, TX
Executive Committee
Carlos L. Arteaga, Vanderbilt-Ingram Cancer Center, Nashville, TN
Powel H. Brown, Baylor College of Medicine, Houston, TX
Joan S. Brugge, Harvard Medical School, Boston, MA
Gary C. Chamness, Baylor College of Medicine, Houston, TX
Charles A. Coltman, Jr., UT Health Science Center, San Antonio, TX
Tyler J. Curiel, UT Health Science Center, San Antonio, TX
Margaret Foti, American Association for Cancer Research, Philadelphia, PA
Anand B. Karnad, UT Health Science Center, San Antonio, TX
C. Kent Osborne, Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, TX
Rajeshwar Rao Tekmal, UT Health Science Center, San Antonio, TX
Program Coordinator
Gary C. Chamness, Baylor College of Medicine,
Houston, TX
Symposia Director
Rich Markow, UT Health Science Center, San Antonio, TX
The majority of participants are physicians and researchers, with
smaller representation by affiliated health care professionals.
The 2007 audience was composed of 44% medical doctors and 11% basic
research scientists. Registrations totaled 8,503 and 86 countries
(including US and Canada) were represented.
In 2007, the 30th Annual San Antonio Breast Cancer Symposium was designated for
continuing medical education. Applications for the same or greater amount of credit will be submitted for the 2008 symposium.
The First Annual San Antonio Breast Cancer Symposium was held
November 11, 1978 during Breast Cancer Awareness Week, and was
part of an intensive 3-year outreach program of public and professional
education designed to significantly reduce the death rate caused
by breast cancer in San Antonio and surrounding counties. It was
sponsored by CTRC and the American Cancer Society, Texas Division,
in conjunction with The University of Texas Health Science Center
at San Antonio (UTHSCSA) and the Bexar County Medical Society.
That all-day course for physicians and surgeons was organized
and co-directed by Charles A. Coltman, Jr., MD and William L.
McGuire, MD, both Professors of Medicine at UTHSCSA. It featured
invited presentations by a panel of internationally known specialists
and was attended by 141 physicians and surgeons from a 5-state
area.
Three years later, in 1981, the meeting was expanded to two days,
a call for abstracts was distributed worldwide, and proffered
papers for slide and poster presentations were incorporated into
the program, thereby broadening its scope to both attract and
draw from a larger, international base. Renowned experts gave
formal plenary lectures, and accepted abstracts were published
for the first time in the peer-reviewed journal Breast Cancer
Research and Treatment. Case discussion lunches offered opportunity
for discussion of complex clinical problems in the management
of primary and metastatic disease, by a panel of physicians from
different disciplines.
Although some modifications have been made in the format, such
as incorporating mini-symposia and, in 1997, the prestigious Brinker
International Awards for Cancer Research program of the Susan
G. Komen Breast Cancer Foundation, the overall format remains
very much the same. This reflects the objective of the Symposium,
which is to provide state-of-the-art information on the experimental
biology, etiology, prevention, diagnosis, and therapy of breast
cancer and premalignant breast disease, to an international audience
of academic and private physicians and researchers.
In 1990, CTRC and UTHSCSA
formally entered into a collaboration known as the San Antonio
Cancer Institute (an NCI-designated Clinical Cancer Center), which
in 1995 assumed direct sponsorship of the Symposium. In 1999,
C. Kent Osborne, MD, Co-Director of the symposium left UTHSCSA
and opened the Breast Center at Baylor College of Medicine.
In 2005, Baylor College of Medicine bacame a joint sponsor of
the symposium.
In 2007, the CTRC merged with UTHSCSA becoming Cancer Therapy & Research Center at UT Health Science Center. Also in 2007, the CTRC at UTHSCSA and the American Association for Cancer Research (AACR) announced a collaboration for the future of the San Antonio Breast Cancer Symposium. The symposium has been renamed the CTRC-AACR San Antonio Breast Cancer Symposium.
UT Health Science Center
San Antonio Medical School, through the Office of Continuing
Medical Education, continues to be the provider of CME sponsorship
for this premier breast cancer symposium.
All administrative functions
are the responsibility of the Symposia Director and occur in the
Symposium operations office, which is located at University Plaza Building, 7526 Louis Pasteur, Room 121, San Antonio, Texas 78229. All proceeds from registration
and abstract fees, industry educational grants, and exhibit fees,
are used for Symposium development and operations, and for support
of its staff which consists of the Symposia Director, the Senior Meeting
Planner, the Assistant Meeting Planner and the Administrative Assistant.
Established by the Susan G. Komen for the Cure in 1992, the Brinker Award for Scientific Distinction recognizes leading scientists for significant work in advancing research concepts and for clinical application in the fields of breast cancer research, screening or treatment. The award is presented to basic and clinical researchers who have made seminal advances in the fight against breast cancer. In addition, the award recognizes scholars for a specific contribution, a consistent pattern of contributions, or leadership in the field that has had a substantial impact on the fight against breast cancer.
The Brinker Award is accompanied by a $20,000 award to be used to further the recipients' activities in breast cancer research. This award has grown in prominence in the breast cancer community and is a marquee award for Komen for the Cure. The recipients of the Brinker Awards will deliver plenary lectures and will also be honored at the 31st Annual San Antonio Breast Cancer Symposium, at a special dinner on Thursday, December 11. [ Ticket required ]